Back to Authors

Churchill, Robert A

0000-0002-6813-5492

Mayo Clinic

Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Citations 5

Clinical characteristics and outcomes of secondary orbital lymphoma
Pecoraro, Trisha YC , Wang, Kenny Y. , Kim, B Michelle , Welk, Grant M. , Churchill, Robert , Tooley, Andrea A. , Dalvin, Lauren A. , Churchill, Robert A , Dalvin, Lauren A , Pecoraro, Trisha Y. C.

European Journal of Ophthalmology | May 16, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/11206721261452074 Get It

Purpose To investigate the clinical features, treatments, and outcomes of patients with secondary orbital lymphoma. Major Findings In this cohort of 31 patients, 15 (48.4%) were female and 27 (87.1%) were white. Follicular lymphoma was the most common subtype (n = 13, 41.9%) and was more associated with unilateral disease compared to other subtypes (p = 0.01). Common presenting symptoms included a palpable mass (n = 17, 54.8%), eyelid swelling (n = 16, 51.6%), and ptosis (n = 12, 38.7%). Patients were most often diagnosed with Ann Arbor Stage IV lymphoma (n = 17, 54.8%) via incisional biopsy (n = 13, 41.9%). Radiation therapy (n = 9, 29.0%) was the most common initial treatment, and most patients received radiation (n = 19, 61.3%) and/or chemotherapy (n = 21, 67.7%). A majority of patients had final best corrected visual acuity (BCVA) within 1 line of initial BCVA (n = 19, 82.6%) and had no local recurrences (n = 21, 67.7%). However, complete remission was rare (n = 3, 9.7%), and systemic recurrence occurred in over half of patients (n = 18, 58.1%). Conclusions Follicular lymphoma was the predominant subtype of secondary orbital lymphoma in this cohort. Most patients with secondary orbital lymphoma presented with advanced disease where few achieved complete remission and more than half of the patients developed systemic recurrence despite majority retaining visual acuity.
Diabetes mellitus is associated with earlier detection of posterior uveal melanoma
Roden, Richard T , Churchill, Robert , White, Launia J. , Hodge, David O. , Madira, Angela E, Myrah, Justin J, Dalvin, Lauren A. , Churchill, Robert A , Fortes, Blake H , Dalvin, Lauren A , Fortes, Blake H. , Madira, Angela E.

European Journal of Ophthalmology | February 4, 2026 | Volume: 36 | Issue: 4 | Pages: 1007-1014

10.1177/11206721261419674 Get It

Purpose To explore the relationship between systemic comorbidities and presenting tumor T category in patients with uveal melanoma. Methods Single-center, retrospective cohort study of patients with posterior uveal melanoma initially diagnosed between January 2000 and December 2016. Univariate and multivariate ordinal logistic regression analyses were performed to identify comorbidities associated with presenting tumor T category, as classified by AJCC criteria. Results Initial presenting AJCC T category was T1 in 190 (43%), T2 in 130 (29%), T3 in 89 (20%), and T4 in 38 (9%). The most common comorbidities present were hypertension (250 patients, 56%), hyperlipidemia (211, 47%), obesity (137, 31%), and diabetes mellitus (87, 19%). Of these, obesity ( p = 0.034), hypertension ( p = 0.017), and diabetes mellitus ( p < 0.001) were associated with earlier presenting T category on univariate ordinal logistic regression. After multivariate regression, only diabetes mellitus ( p = 0.01) and obesity ( p = 0.04) remained significantly associated with earlier T category on initial presentation. Conclusion Among patients presenting with uveal melanoma, diabetes mellitus and obesity were associated with earlier presenting T category, which could reflect earlier detection of uveal melanoma in patients undergoing annual diabetic retinopathy screening examinations or having more frequent contact with the healthcare system. Larger studies should further explore this association and examine the utility of increased ocular screening in early detection of uveal melanoma.
Clinical characteristics and outcomes of primary orbital lymphoma
Wang, Kenny Y. , Kim, B. Michelle, Yu, Caroline , Welk, Grant M. , Churchill, Robert , White, Launia J. , Hodge, David O. , Dalvin, Lauren A. , Tooley, Andrea A. , Yu, Caroline Y, Churchill, Robert A , Dalvin, Lauren A

European Journal of Ophthalmology | April 29, 2025 | Volume: 35 | Issue: 5 | Pages: 1776-1785

10.1177/11206721251338705 Get It

Purpose To describe the clinical characteristics, histopathologic subtype distribution, treatment, and outcomes of patients with primary orbital lymphoma. Major Findings There were 126 biopsy-confirmed cases of primary orbital lymphoma, with 81 (64.3%) female and 110 (87.3%) white. The average age at diagnosis was 62.7 ± 13.9 years. There were 26 (20.6%) cases with bilateral involvement. The most frequent lymphoma subtype was MALT lymphoma (N = 76, 60.3%), followed by diffuse large B-cell lymphoma (N = 18, 14.3%) and follicular lymphoma (N = 12, 9.5%). Prognosis was generally favorable, as local recurrence occurred in only 14 (11.1%) patients and final best corrected visual acuity (BCVA) loss of >1 line was seen in 30 (28.0%) patients. Bilateral lymphoma and advanced stage (Ann Arbor Stage III or IV) at presentation were associated with increased risk of local recurrence ( p = 0.0025, p = 0.049). Improved disease-specific survival was associated with diagnosis at Stage I or II ( p = 0.013), MALT subtype ( p = 0.034), or lack of chemotherapy requirement as primary treatment ( p = 0.0073). Conclusions In this single center academic cohort, MALT lymphoma subtype was most common. Overall orbital recurrence frequency was low, and bilateral lymphoma and advanced stage were associated with increased risk of local recurrence. MALT lymphoma subtype was associated with improved disease-specific survival. Long-term follow-up showed that most patients retained good visual acuity in the affected eye(s).
Association of cardiac biomarkers with long-term cardiovascular events in a community cohort
Churchill, Robert , Gochanour, Benjamin R. , Scott, Christopher G. , Vasile, Vlad C. , Rodeheffer, Richard J. , Meeusen, Jeffrey W. , Jaffe, Allan S. , Churchill, Robert A , Scott, Christopher , Vasile, Vlad , Meeusen, Jeffrey W. , Jaffe, Allan S.

Biomarkers | April 26, 2024 | Volume: 29 | Issue: 4 | Pages: 161-170

10.1080/1354750x.2024.2335245 Get It

Diagnosing Smoldering Multiple Myeloma and Light Chain Amyloidosis in the Setting of Severe Transthyretin Amyloid Cardiomyopathy and Extracardiac Sarcoidosis
Churchill, Robert , Rosenbaum, Andrew , Churchill, Robert A

Annals of Internal Medicine: Clinical Cases | April 2, 2024 | Volume: 3 | Issue: 4 | Pages: No page available

10.7326/aimcc.2023.1117 Get It